McKesson (BSP:M1CK34) Valuation Rank

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BSP:M1CK34 McKesson Corp BSP:M1CK34
83 GF Score
Price R$1,086.09
GF Value R$1,018.13
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is McKesson Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.


McKesson Valuation Rank Related Terms

BSP:M1CK34
83GF Score
McKesson Corp BSP:M1CK34
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is McKesson (BSP:M1CK34) Overvalued in 2026?

Based on GuruFocus' analysis, McKesson stock appears to be overvalued. The current stock price of R$1,086.09 is trading 6.7% above its estimated GF Value™ of R$1,018.13. GuruFocus considers McKesson to be Fairly Valued.

Key valuation signals for BSP:M1CK34:

  • Valuation Rank:
  • GF Value™: R$1,018.13 vs. price of R$1,086.09 (6.7% above fair value)
  • GF Score™: 83/100 with 2 warning signs

No single metric tells the full story. See the BSP:M1CK34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


McKesson Business Description

Address 6555 State Highway 161, Irving, TX, USA, 75039
McKesson is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
83GF Score

Get the complete analysis for BSP:M1CK34

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$1,086.09
Price
R$1,018.13
GF Value